Physician profile
Jenny E Potter
NPI 1427413491
$1,990.44
in general payments reported to CMS, 2019-2025
16 companies · $963 in 2025
The $963 reported for 2025 was more than what 80% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $205 · 2022: $235 · 2023: $295 · 2024: $293 · 2025: $963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,383 · Education: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,383.38 |
| Education | $166.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $493.40 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $404.01 | 2021-2025 | |
| Janssen Biotech, INC. | $241.54 | 2023-2025 | Tremfya |
| Amgen INC. | $139.91 | 2022-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $139.59 | 2023-2025 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $130.87 | 2021-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $108.03 | 2022-2025 | |
| Incyte Corporation | $85.46 | 2024-2025 | Opzelura |
| Genzyme Corporation | $71.55 | 2021-2025 | |
| Lilly USA, LLC | $56.21 | 2024-2025 | Ebglyss, Olumiant |
| Mayne Pharma Commercial LLC | $33.79 | 2025 | |
| Organon LLC | $21.99 | 2025 | Vtama |
| Botanix Sb INC | $19.53 | 2025 | Sofdra |
| Journey Medical Corporation | $19.09 | 2025 | |
| Galderma Laboratories, L.P. | $13.32 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Potter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.